erythema nodosum


Also found in: Dictionary, Thesaurus, Medical, Wikipedia.
Related to erythema nodosum: erythema multiforme, sarcoidosis

erythema nodosum

[‚er·ə′thē·mə nō′dō·səm]
(medicine)
The occurrence of pink to blue, tender nodules on the anterior surfaces of the lower legs; more frequent in women than men.
References in periodicals archive ?
An uncommon complication that may occur among both treated and untreated patients is the reactional episode, of which there are two types: type 1 or reversal reaction and type 2 reaction, also known as erythema nodosum leprosum.
Erythema nodosum was also quite infrequently encountered in older patients.
An outbreak of gastrointestinal illness and erythema nodosum from grated carrots contaminated with Yersinia pseudotuberculosis.
Erythema nodosum leprosum and HIV infection: a therapeutic experience.
CELG) won the FDA's blessing for offering its own thalidomide formulation, brand-named Thalomid, in the treatment of erythema nodosum leprosum (ENL), an inflammatory complication of leprosy.
About 10% develop other conditions linked with Crohn's, including a form of arthritis known as ankylosing spondylitis, kidney stones, gallstones and a rash called erythema nodosum.
The organism can also cause mesenteric lymphadenitis, which mimics appendicitis, or infection at other body sites that occasionally leads to postinfectious sequelae such as reactive arthritis and erythema nodosum (1).
In July 1998, Celgene received FDA clearance to market and sell THALOMID(TM) for the treatment of erythema nodosum leprosum (ENL), an inflammatory complication of leprosy.
Twelve patients had fever with no other symptoms when they sought medical attention (7), six had arthritis in one or several joints (two with sacroilieitis), and five had erythema nodosum.
Food and Drug Administration (FDA) for thalidomide in the treatment of the cutaneous manifestations of erythema nodosum leprosum (ENL), a severe and debilitating condition associated with leprosy.
THALOMID, approved for the acute treatment of cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL) and as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrence, potentially causes severe birth defects or death to an unborn baby.